Entecavir 65862-0841-30
- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 26, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA206217
Need to source Entecavir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Entecavir | .5 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Nucleoside Analog [EXT]Nucleoside Reverse Transcriptase Inhibitors [MoA]
Selected Package
65862-0841-30Selected1 BOTTLE in 1 CARTON (65862-841-30) / 30 TABLET in 1 BOTTLE
Other packages for this product(2)
1 BOTTLE in 1 CARTON (65862-841-90) / 90 TABLET in 1 BOTTLE
1 BOTTLE in 1 CARTON (65862-841-99) / 1000 TABLET in 1 BOTTLE